press release from nz health minister on 21.05, page-4

Thank u for posting the press release. I note that there is recogition by the minister of the value that LCT offers in his comment of balance where he stated "....high probability of a positive impact on a limited number of diabetes sufferers needs to be balanced against the low probability of a potentially very serious porcine retrovirus....". That low probability is next to zip, with centuries of people living in close proximity to pigs there has NEVER been a case of transfer of the retrovirus. What he forgot to mention is that four patients in New Zealand have already received live pig cells without adverse side effects and the process is being carried out in other countries as we speak. The NZ government have the ability to monitor the process if they allow it in their country. If they don't patients will get the treatment done in other countries and NZ will have no control over the situation. The US realised this years ago and the Centre for Disease Control has allocated funds to store implanted tissue samples and provision for a database to keep track of patients. New Zealand could be at the forefront of this new technology (which technically through LCT it is) or it can sit on its hands and let the opportunity be picked up by a more insightful group of politicians.
In Summary, LCT are progressing their trials in Russia and expanding thier contacts for clinical trials in the US which will lead to ultimate success. From an investors point of view, the delay in sign off by the minister will only affect the value of NZ as a country, LCT's value is not going to be held back by lack of descision making ability by a politician in a back water country on the bottom of the world. (No offence to Kiwis in general, some of my best friends are Kiwis).